Cover Image
市場調查報告書

全球老鼠模型市場趨勢,機器分析,市場佔有率,預測

Global Rat Model Market Insights, Opportunity Analysis, Market Shares and Forecast, 2016 - 2022

出版商 Occams Business Research & Consulting Pvt. Ltd. 商品編碼 384993
出版日期 內容資訊 英文 140 Pages
商品交期: 請詢問到貨日
價格
Back to Top
全球老鼠模型市場趨勢,機器分析,市場佔有率,預測 Global Rat Model Market Insights, Opportunity Analysis, Market Shares and Forecast, 2016 - 2022
出版日期: 2016年11月08日 內容資訊: 英文 140 Pages
簡介

全球老鼠模型市場預計從2016年到2022年以9.6%擴大,2022年達到3億5,850萬美元。老鼠模型由於監測的容易度和學習能力,胚芽細胞生產速度快速等,在研究中有多個優點。

本報告提供全球老鼠模型市場相關調查,各市場區隔趨勢,競爭趨勢,各地區趨勢,及加入此市場的主要企業簡介等彙整資料。

第1章 簡介

  • 摘要整理
  • 市場範圍

第2章 市場概要

  • 發展和變遷
  • 產業結構
  • 製造流程
  • 相關法規
  • 市場分析
  • 預測分析
  • 策略分析
  • 競爭分析
  • 策略性建議和結論

第3章 市場決策因素

  • 推動市場的要素與市場的影響
  • 阻礙市場的要素與市場的影響
  • 市場機會
  • 市場課題

第4章 市場區隔

  • 各類型
  • 各技術
  • 各用途
  • 各老鼠照顧產品
  • 各類服務

第5章 競爭環境

  • 主要策略
  • 10家大企業分析

第6章 各地區市場

  • 支持決策的資料庫與預測方法
  • 市場區隔的比較分析
  • 機會矩陣
  • 各地區市場區隔
    • 北美
    • 歐洲
    • 亞太地區
    • 其他各國

第7章 企業簡介

  • BIOMEDICAL RESEARCH MODEL INC.,
  • CHARLES RIVER LABORATORIES INC.,
  • COVANCE INC.,
  • GENOWAY S. A.
  • HARLAN LABORATORIES INC.,
  • JANVIER LABS
  • SAGE LABS
  • TACONIC BIOSCIENCE INC.,
  • TRANSPOSAGEN BIOPHARMACEUTICALS INC.,
  • TRANSVIRAGEN INC.,
  • HERA BIOLABS INC.,
  • ONCODESIGN LTD.,
  • CYAGEN INC.,
  • VIVO BIOTECH LTD.,
  • 日本Crea株式會社

圖表

目錄
Product Code: HAD-4011116

The global rat model market is expected to reach above $358.5million in 2022 and is anticipated to grow at a CAGR of 9.6% during 2016 to 2022.

Rats have a benefit over other rodent models for pre-clinical and research studies. Ease of monitoring, learning abilities and faster producing embryo cells are some of the advantages of rat models in research. The main drivers of rat model market are applications of personalized human rat models and research & development of pharmaceutical & biotechnology companies. Growing demand for in vitro testing models for research and ethical approach towards animals used in research might challenge rat model market growth for the forecasted period 2016-2022.

Innovations in Genetic Engineering appending demand for genetically modified rat models, advantage of rats over mice in life science research, and research & development of pharmaceutical and biotechnology companies are the drivers for rat model market deliberated in the research report. Growing demand from emerging economies, increase in monoclonal antibody production, and research in personalized medicine increasing demand for rat models, are the opportunities in rat model market analysed in the report.

Ethical use of animals in research, varying regulatory environment with respect to animals in research, increasing adoption of zebrafish model for research, and new in vitro testing models for research are the factors restraining market growth of rat model market for the forecasted period.

The research report is segmented as rat types, technology, application, rat care products and services. Market segment by rat types are further sub segmented into inbred rats, genetically modified rats, hybrid rats, outbred rats and immune-deficient rats. Outbred rats have a higher demand for toxicology research. Technology segment is further divided into nuclear transferase technology, micro injection, embryonic stem cell injection and others. Application segment is classified further into diabetes, toxicology, oncology, immunology & inflammation and others. Rat care products segment in further sub segmented into feed, bedding, cages and others. Service segment is further divided into cryopreservation, breeding, genetic testing and others. Cryopreservation has significant growth rate in the service segment due to less cost to maintain rat strain for a longer time.

The research report analysed rat model market geographically. Region wise the report is segmented as North America, Europe, Asia Pacific, and Rest of the World. North America is the largest rat model market, followed by Europe. Increasing demand for rats in pre-clinical animal trail studies by CROs, pharmaceutical companies, and life science research institutions and availability various types of rat models are the factors driving rat model market in North America for the forecasted period. Rising demand for monoclonal antibodies, growing stem cell research, and clear regulation by European parliament with respect to use of animals in research are the main factors driving rat model market in Europe. Asia Pacific is the fastest growing rat model market for the forecasted period. With increasing expenditure on research & development in life science by government, rising demand from emerging economies like India and China, increasing clinical trial research studies by CRO's and pharmaceutical companies, are the main factors driving rat model market in Asia Pacific for the forecasted period.

Some of the leading companies in rat model market are, Envigo., Charles River Laboratories International Inc., Taconic Biosciences Inc., The Jackson Laboratory., Covance Inc., Janvier Labs., Harbour Antibodies Bv., Transgenic Inc., Genoway S. A., Sage Labs Inc., Ingenious Targeting Laboratory and many more. The report provides comprehensive information like company profile, sales, revenue, market share and contact information.

Hera BioLabs Inc., on 28th April 2016 announced an investment of $1.8million for its new headquarters in Lexington, U.S. Joint ventures, agreements, partnerships, collaborations, expansion in different countries, and strengthening supply chain network with distributors are some of the strategies taken by pioneers in rat model market, to increase their global presence. Research & development investments are high with the urge to new type of rat models. Small rat model companies with unique and differentiated assets (like disease specific rats production) are driving innovation in rat model market.

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. EXECUTIVE SUMMARY
  • 1.2. MARKET SCOPE

2. MARKET OVERVIEW

  • 2.1. GLOBAL RAT MODEL MARKET : EVOLUTION & TRANSITION
  • 2.2. INDUSTRY STRUCTURE
  • 2.3. MANUFACTURING PROCESS
  • 2.4. REGULATORY FRAMEWORK
  • 2.5. TOTAL MARKET ANALYSIS
    • 2.5.1. TOP 5 FINDINGS
    • 2.5.2. TOP 5 OPPORTUNITY MARKETS
    • 2.5.3. TOP 5 COMPANIES
    • 2.5.4. TOP 3 COMPETITIVE STRATEGIES
  • 2.6. ESTIMATION ANALYSIS
  • 2.7. STRATEGIC ANALYSIS
    • 2.7.1. INVESTMENT VS. ADOPTION MODEL
    • 2.7.2. 360 DEGREE INDUSTRY ANALYSIS
    • 2.7.3. PORTERS 5 FORCE MODEL
    • 2.7.4. SEE-SAW ANALYSIS
    • 2.7.5. PRICING ANALYSIS
    • 2.7.6. CONSUMER ANALYSIS AND KEY BUYING CRITERIA
    • 2.7.7. ROI ANALYSIS
    • 2.7.8. GAP ANALYSIS
  • 2.8. COMPETITIVE ANALYSIS
    • 2.8.1. KEY STRATEGIES AND ANALYSIS
    • 2.8.2. MARKET SHARE
    • 2.8.3. TOP COMPANY ANALYSIS
  • 2.9. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS
    • 2.9.1. INVESTMENT OPPORTUNITIES BY REGIONS
    • 2.9.2. OPPORTUNITIES IN EMERGING APPLICATIONS
    • 2.9.3. INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT

3. MARKET DETERMINANTS

  • 3.1. MARKET DRIVERS & MARKET IMPACT
    • 3.1.1. INNOVATIONS IN GENETIC ENGINEERING SUPPLEMENTS DEMAND FOR GENETICALLY MODIFIED RAT MODELS
    • 3.1.2. ADVANTAGE OF RATS OVER MICE IN LIFE SCIENCE RESEARCH
    • 3.1.3. RESEARCH & DEVELOPMENT OF PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES.
  • 3.2. MARKET RESTRAINTS & MARKET IMPACT
    • 3.2.1. ETHICAL USE OF ANIMALS IN RESEARCH
    • 3.2.2. VARYING REGULATORY ENVIRONMENT WITH RESPECT TO ANIMALS IN RESEARCH
    • 3.2.3. INCREASING ADOPTION OF ZEBRAFISH MODEL FOR RESEARCH
    • 3.2.4. NEW IN VITRO TESTING MODELS FOR RESEARCH
  • 3.3. MARKET OPPORTUNITIES
    • 3.3.1. GROWING DEMAND FROM EMERGING ECONOMIES.
    • 3.3.2. RESEARCH IN PERSONALIZED MEDICINE SET TO INCREASE DEMAND
    • 3.3.3. INCREASE IN MONOCLONAL ANTIBODY PRODUCTION.
  • 3.4. MARKET CHALLENGES
    • 3.4.1. NEWLY IMPROVED RAT MODELS

4. MARKET SEGMENTATION

  • 4.1. GLOBAL RAT MODEL MARKET BY RAT TYPES 2014-2022 ($ MILLION)
    • 4.1.1. MARKET DEFINITION AND SCOPE
    • 4.1.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
    • 4.1.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
    • 4.1.4. OPPORTUNITY MATRIX
    • 4.1.5. MARKET SEGMENTATION
      • 4.1.5.1. INBRED RATS 2014-2022 ($ MILLION)
      • 4.1.5.2. GENETICALLY ENGINEERED RATS 2014-2022 ($ MILLION)
      • 4.1.5.3. SURGICALLY MODIFIED RATS 2014-2022 ($ MILLION)
      • 4.1.5.4. HYBRID RATS 2014-2022 ($ MILLION)
      • 4.1.5.5. OUTBRED RATS 2014-2022 ($ MILLION)
      • 4.1.5.6. IMMUNE-DEFICIENT RATS 2014-2022 ($ MILLION)
  • 4.2. GLOBAL RAT MODELS MARKET BY TECHNOLOGY 2014-2022 ($ MILLION)
    • 4.2.1. MARKET DEFINITION AND SCOPE
    • 4.2.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
    • 4.2.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
    • 4.2.4. OPPORTUNITY MATRIX
    • 4.2.5. MARKET SEGMENTATION
      • 4.2.5.1. NUCLEAR TRANSFERASE TECHNOLOGY 2014-2022 ($ MILLION)
      • 4.2.5.2. MICRO INJECTION 2014-2022 ($ MILLION)
      • 4.2.5.3. EMBRYONIC STEM CELL INJECTION 2014-2022 ($ MILLION)
      • 4.2.5.4. OTHER TECHNOLOGY 2014-2022 ($ MILLION)
  • 4.3. GLOBAL RAT MODEL MARKET BY APPLICATION 2014-2022 ($ MILLION)
    • 4.3.1. MARKET DEFINITION AND SCOPE
    • 4.3.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
    • 4.3.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
    • 4.3.4. OPPORTUNITY MATRIX
    • 4.3.5. MARKET SEGMENTATION
      • 4.3.5.1. DIABETES 2014-2022 ($ MILLION)
      • 4.3.5.2. TOXICOLOGY 2014-2022 ($ MILLION)
      • 4.3.5.3. ONCOLOGY 2014-2022 ($ MILLION)
      • 4.3.5.4. IMMUNOLOGY & INFLAMMATION 2014-2022 ($ MILLION)
      • 4.3.5.5. OTHER DISEASES 2014-2022 ($ MILLION)
  • 4.4. GLOBAL RAT MODEL MARKET BY RAT CARE PRODUCTS 2014-2022 ($ MILLION)
    • 4.4.1. MARKET DEFINITION AND SCOPE
    • 4.4.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
    • 4.4.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
    • 4.4.4. OPPORTUNITY MATRIX
    • 4.4.5. MARKET SEGMENTATION
      • 4.4.5.1. FEED 2014-2022 ($ MILLION)
      • 4.4.5.2. BEDDING 2014-2022 ($ MILLION)
      • 4.4.5.3. CAGES 2014-2022 ($ MILLION)
      • 4.4.5.4. OTHER CARE PRODUCTS 2014-2022 ($ MILLION)
  • 4.5. GLOBAL RAT MODEL MARKET BY SERVICE 2014-2022 ($ MILLION)
    • 4.5.1. MARKET DEFINITION AND SCOPE
    • 4.5.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
    • 4.5.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
    • 4.5.4. OPPORTUNITY MATRIX
    • 4.5.5. MARKET SEGMENTATION
      • 4.5.5.1. CRYOPRESERVATION 2014-2022 ($ MILLION)
      • 4.5.5.2. BREEDING 2014-2022 ($ MILION)
      • 4.5.5.3. GENETIC TESTING 2014-2022 ($ MILLION)
      • 4.5.5.4. OTHER SERVICES 2014-2022 ($ MILLION)

5. COMPETITIVE LANDSCAPE

  • 5.1. KEY STRATEGIES
    • 5.1.1. LIST OF M&A
    • 5.1.2. LIST OF JV
    • 5.1.3. LIST OF PRODUCT LAUNCHES
    • 5.1.4. LIST OF PARTNERSHIP
  • 5.2. TOP 10 COMPANY ANALYSIS - DASHBOARD

6. GLOBAL RAT MODEL MARKET BY REGION (REVENUE ANALYSIS) 2014-2022 ($ MILLION)

  • 6.1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
  • 6.2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
  • 6.3. OPPORTUNITY MATRIX
  • 6.4. GEOGRAPHIC SEGMENTATION
    • 6.4.1. NORTH AMERICA
      • 6.4.1.1. INDUSTRY APPLICATION ANALYSIS
      • 6.4.1.2. TOP COUNTRY ANALYSIS
        • 6.4.1.2.1. U.S.
          • 6.4.1.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
          • 6.4.1.2.1.2. MARKET REVENUES 2014-2022 ($ MILLION)
          • 6.4.1.2.1.3. PRICE ANALYSIS
          • 6.4.1.2.1.4. TOP PLAYERS & KEY PRODUCTS
          • 6.4.1.2.1.5. KEY CONCLUSIONS
        • 6.4.1.2.2. CANADA
          • 6.4.1.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
          • 6.4.1.2.2.2. MARKET REVENUES 2014-2022 ($ MILLION)
          • 6.4.1.2.2.3. PRICE ANALYSIS
          • 6.4.1.2.2.4. TOP PLAYERS & KEY PRODUCTS
          • 6.4.1.2.2.5. KEY CONCLUSIONS
    • 6.4.2. EUROPE
      • 6.4.2.1. INDUSTRY APPLICATION ANALYSIS
      • 6.4.2.2. TOP COUNTRY ANALYSIS
        • 6.4.2.2.1. UK
          • 6.4.2.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
          • 6.4.2.2.1.2. MARKET REVENUES 2014-2022 ($ MILLION)
          • 6.4.2.2.1.3. PRICE ANALYSIS
          • 6.4.2.2.1.4. TOP PLAYERS & KEY PRODUCTS
          • 6.4.2.2.1.5. KEY CONCLUSIONS
        • 6.4.2.2.2. FRANCE
          • 6.4.2.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
          • 6.4.2.2.2.2. MARKET REVENUES 2014-2022 ($ MILLION)
          • 6.4.2.2.2.3. PRICE ANALYSIS
          • 6.4.2.2.2.4. TOP PLAYERS & KEY PRODUCTS
          • 6.4.2.2.2.5. KEY CONCLUSIONS
        • 6.4.2.2.3. GERMANY
          • 6.4.2.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
          • 6.4.2.2.3.2. MARKET REVENUES 2014-2022 ($ MILLION)
          • 6.4.2.2.3.3. PRICE ANALYSIS
          • 6.4.2.2.3.4. TOP PLAYERS & KEY PRODUCTS
          • 6.4.2.2.3.5. KEY CONCLUSIONS
        • 6.4.2.2.4. SPAIN
          • 6.4.2.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
          • 6.4.2.2.4.2. MARKET REVENUES 2014-2022 ($ MILLION)
          • 6.4.2.2.4.3. PRICE ANALYSIS
          • 6.4.2.2.4.4. TOP PLAYERS & KEY PRODUCTS
          • 6.4.2.2.4.5. KEY CONCLUSIONS
        • 6.4.2.2.5. ITALY
          • 6.4.2.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
          • 6.4.2.2.5.2. MARKET REVENUES 2014-2022 ($ MILLION)
          • 6.4.2.2.5.3. PRICE ANALYSIS
          • 6.4.2.2.5.4. TOP PLAYERS & KEY PRODUCTS
          • 6.4.2.2.5.5. KEY CONCLUSIONS
        • 6.4.2.2.6. REST OF EUROPE
          • 6.4.2.2.6.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
          • 6.4.2.2.6.2. MARKET REVENUES 2014-2022 ($ MILLION)
          • 6.4.2.2.6.3. PRICE ANALYSIS
          • 6.4.2.2.6.4. TOP PLAYERS & KEY PRODUCTS
          • 6.4.2.2.6.5. KEY CONCLUSIONS
    • 6.4.3. ASIA PACIFIC
      • 6.4.3.1. INDUSTRY APPLICATION ANALYSIS
      • 6.4.3.2. TOP COUNTRY ANALYSIS
        • 6.4.3.2.1. CHINA
          • 6.4.3.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
          • 6.4.3.2.1.2. MARKET REVENUES 2014-2022 ($ MILLION)
          • 6.4.3.2.1.3. PRICE ANALYSIS
          • 6.4.3.2.1.4. TOP PLAYERS & KEY PRODUCTS
          • 6.4.3.2.1.5. KEY CONCLUSIONS
        • 6.4.3.2.2. INDIA
          • 6.4.3.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
          • 6.4.3.2.2.2. MARKET REVENUES 2014-2022 ($ MILLION)
          • 6.4.3.2.2.3. PRICE ANALYSIS
          • 6.4.3.2.2.4. TOP PLAYERS & KEY PRODUCTS
          • 6.4.3.2.2.5. KEY CONCLUSIONS
        • 6.4.3.2.3. JAPAN
          • 6.4.3.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
          • 6.4.3.2.3.2. MARKET REVENUES 2014-2022 ($ MILLION)
          • 6.4.3.2.3.3. PRICE ANALYSIS
          • 6.4.3.2.3.4. TOP PLAYERS & KEY PRODUCTS
          • 6.4.3.2.3.5. KEY CONCLUSIONS
        • 6.4.3.2.4. SOUTH KOREA
          • 6.4.3.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
          • 6.4.3.2.4.2. MARKET REVENUES 2014-2022 ($ MILLION)
          • 6.4.3.2.4.3. PRICE ANALYSIS
          • 6.4.3.2.4.4. TOP PLAYERS & KEY PRODUCTS
          • 6.4.3.2.4.5. KEY CONCLUSIONS
        • 6.4.3.2.5. AUSTRALIA
          • 6.4.3.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
          • 6.4.3.2.5.2. MARKET REVENUES 2014-2022 ($ MILLION)
          • 6.4.3.2.5.3. PRICE ANALYSIS
          • 6.4.3.2.5.4. TOP PLAYERS & KEY PRODUCTS
          • 6.4.3.2.5.5. KEY CONCLUSIONS
        • 6.4.3.2.6. REST OF ASIA PACIFIC
          • 6.4.3.2.6.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
          • 6.4.3.2.6.2. MARKET REVENUES 2014-2022 ($ MILLION)
          • 6.4.3.2.6.3. PRICE ANALYSIS
          • 6.4.3.2.6.4. TOP PLAYERS & KEY PRODUCTS
          • 6.4.3.2.6.5. KEY CONCLUSIONS
    • 6.4.4. REST OF THE WORLD
      • 6.4.4.1. INDUSTRY APPLICATION ANALYSIS
      • 6.4.4.2. TOP COUNTRY ANALYSIS
        • 6.4.4.2.1. LATIN AMERICA
          • 6.4.4.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
          • 6.4.4.2.1.2. MARKET REVENUES 2014-2022 ($ MILLION)
          • 6.4.4.2.1.3. PRICE ANALYSIS
          • 6.4.4.2.1.4. TOP PLAYERS & KEY PRODUCTS
          • 6.4.4.2.1.5. KEY CONCLUSIONS
        • 6.4.4.2.2. MIDDLE EAST & NORTH AFRICA
          • 6.4.4.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
          • 6.4.4.2.2.2. MARKET REVENUES 2014-2022 ($ MILLION)
          • 6.4.4.2.2.3. PRICE ANALYSIS
          • 6.4.4.2.2.4. TOP PLAYERS & KEY PRODUCTS
          • 6.4.4.2.2.5. KEY CONCLUSIONS
        • 6.4.4.2.3. AFRICA
          • 6.4.4.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
          • 6.4.4.2.3.2. MARKET REVENUES 2014-2022 ($ MILLION)
          • 6.4.4.2.3.3. PRICE ANALYSIS
          • 6.4.4.2.3.4. TOP PLAYERS & KEY PRODUCTS
          • 6.4.4.2.3.5. KEY CONCLUSIONS

7. COMPANY PROFILES

  • 7.1. BIOMEDICAL RESEARCH MODEL INC.,
    • 7.1.1. OVERVIEW
    • 7.1.2. PRODUCT PORTFOLIO
    • 7.1.3. KEY INNOVATION SECTOR
    • 7.1.4. STRATEGIC INITIATIVES
    • 7.1.5. SCOT ANALYSIS
  • 7.2. CHARLES RIVER LABORATORIES INC.,
    • 7.2.1. OVERVIEW
    • 7.2.2. PRODUCT PORTFOLIO
    • 7.2.3. KEY INNOVATION SECTOR
    • 7.2.4. STRATEGIC INITIATIVES
    • 7.2.5. SCOT ANALYSIS
  • 7.3. COVANCE INC.,
    • 7.3.1. OVERVIEW
    • 7.3.2. PRODUCT PORTFOLIO
    • 7.3.3. KEY INNOVATION SECTOR
    • 7.3.4. STRATEGIC INITIATIVES
    • 7.3.5. SCOT ANALYSIS
  • 7.4. GENOWAY S. A.
    • 7.4.1. OVERVIEW
    • 7.4.2. PRODUCT PORTFOLIO
    • 7.4.3. KEY INNOVATION SECTOR
    • 7.4.4. STRATEGIC INITIATIVES
    • 7.4.5. SCOT ANALYSIS
  • 7.5. HARLAN LABORATORIES INC.,
    • 7.5.1. OVERVIEW
    • 7.5.2. PRODUCT PORTFOLIO
    • 7.5.3. KEY INNOVATION SECTOR
    • 7.5.4. STRATEGIC INITIATIVES
    • 7.5.5. SCOT ANALYSIS
  • 7.6. JANVIER LABS
    • 7.6.1. OVERVIEW
    • 7.6.2. PRODUCT PORTFOLIO
    • 7.6.3. KEY INNOVATION SECTOR
    • 7.6.4. STRATEGIC INITIATIVES
    • 7.6.5. SCOT ANALYSIS
  • 7.7. SAGE LABS
    • 7.7.1. OVERVIEW
    • 7.7.2. PRODUCT PORTFOLIO
    • 7.7.3. KEY INNOVATION SECTOR
    • 7.7.4. STRATEGIC INITIATIVES
    • 7.7.5. SCOT ANALYSIS
  • 7.8. TACONIC BIOSCIENCE INC.,
    • 7.8.1. OVERVIEW
    • 7.8.2. PRODUCT PORTFOLIO
    • 7.8.3. KEY INNOVATION SECTOR
    • 7.8.4. STRATEGIC INITIATIVES
    • 7.8.5. SCOT ANALYSIS
  • 7.9. TRANSPOSAGEN BIOPHARMACEUTICALS INC.,
    • 7.9.1. OVERVIEW
    • 7.9.2. PRODUCT PORTFOLIO
    • 7.9.3. KEY INNOVATION SECTOR
    • 7.9.4. STRATEGIC INITIATIVES
    • 7.9.5. SCOT ANALYSIS
  • 7.10. TRANSVIRAGEN INC.,
    • 7.10.1. OVERVIEW
    • 7.10.2. PRODUCT PORTFOLIO
    • 7.10.3. KEY INNOVATION SECTOR
    • 7.10.4. STRATEGIC INITIATIVES
    • 7.10.5. SCOT ANALYSIS
  • 7.11. HERA BIOLABS INC.,
    • 7.11.1. OVERVIEW
    • 7.11.2. PRODUCT PORTFOLIO
    • 7.11.3. KEY INNOVATION SECTOR
    • 7.11.4. STRATEGIC INITIATIVES
    • 7.11.5. SCOT ANALYSIS
  • 7.12. ONCODESIGN LTD.,
    • 7.12.1. OVERVIEW
    • 7.12.2. PRODUCT PORTFOLIO
    • 7.12.3. KEY INNOVATION SECTOR
    • 7.12.4. STRATEGIC INITIATIVES
    • 7.12.5. SCOT ANALYSIS
  • 7.13. CYAGEN INC.,
    • 7.13.1. OVERVIEW
    • 7.13.2. PRODUCT PORTFOLIO
    • 7.13.3. KEY INNOVATION SECTOR
    • 7.13.4. STRATEGIC INITIATIVES
    • 7.13.5. SCOT ANALYSIS
  • 7.14. VIVO BIOTECH LTD.,
    • 7.14.1. OVERVIEW
    • 7.14.2. PRODUCT PORTFOLIO
    • 7.14.3. KEY INNOVATION SECTOR
    • 7.14.4. STRATEGIC INITIATIVES
    • 7.14.5. SCOT ANALYSIS
  • 7.15. CLEA JAPAN
    • 7.15.1. OVERVIEW
    • 7.15.2. PRODUCT PORTFOLIO
    • 7.15.3. KEY INNOVATION SECTOR
    • 7.15.4. STRATEGIC INITIATIVES
    • 7.15.5. SCOT ANALYSIS

LIST OF TABLES

  • TABLE 1. GLOBAL RAT MODEL MARKET BY RAT TYPE 2014-2022 ($ MILLION)
  • TABLE 2. GLOBAL RAT MODEL MARKET BY TECHNOLOGY 2014-2022 ($ MILLION)
  • TABLE 3. GLOBAL RAT MODEL MARKET BY APPLICATION 2014-2022 ($ MILLION)
  • TABLE 4. GLOBAL RAT MODEL MARKET BY RAT CARE PRODUCTS 2014-2022 ($ MILLION)
  • TABLE 5. GLOBAL RAT MODEL MARKET BY SERVICES 2014-2022 ($ MILLION)
  • TABLE 6. NORTH AMERICA RAT MODEL MARKET 2014-2022 ($ MILLION)
  • TABLE 7. EUROPE RAT MODEL MARKET 2014-2022 ($ MILLION)
  • TABLE 8. ASIA PACIFIC RAT MODEL MARKET 2014-2022 ($ MILLION)
  • TABLE 9. REST OF THE WORLD RAT MODEL MARKET 2014-2022 ($ MILLION)

LIST OF FIGURES

  • FIGURE 10. GLOBAL RAT MODEL MARKET BY INBRED RATS 2014-2022 ($ MILLION)
  • FIGURE 11. GLOBAL RAT MODEL MARKET BY GENETICALLY ENGINEERED RATS 2014-2022 ($ MILLION)
  • FIGURE 12. GLOBAL RAT MODEL MARKET BY SURGICALLY MODIFIED RATS 2014-2022 ($ MILLION)
  • FIGURE 13. GLOBAL RAT MODEL MARKET BY HYBRID RATS 2014-2022 ($ MILLION)
  • FIGURE 14. GLOBAL RAT MODEL MARKET BY IMMUNE DEFICIENT RATS 2014-2022 ($ MILLION)
  • FIGURE 15. GLOBAL RAT MODEL MARKET BY NUCLEAR TRANSFERASE TECHNOLOGY 2014-2022 ($ MILLION)
  • FIGURE 16. GLOBAL RAT MODEL MARKET BY MICRO INJECTION 2014-2022 ($ MILLION)
  • FIGURE 17. GLOBAL RAT MODEL MARKET BY EMBRYONIC STEM CELL INJECTION 2014-2022 ($ MILLION)
  • FIGURE 18. GLOBAL RAT MODEL MARKET BY OTHER TECHNOLOGY 2014-2022 ($ MILLION)
  • FIGURE 19. GLOBAL RAT MODEL MARKET BY DIABETES 2014-2022 ($ MILLION)
  • FIGURE 20. GLOBAL RAT MODEL MARKET BY TOXICOLOGY 2014-2022 ($ MILLION)
  • FIGURE 21. GLOBAL RAT MODEL MARKET BY ONCOLOGY 2014-2022 ($ MILLION)
  • FIGURE 22. GLOBAL RAT MODEL MARKET BY IMMUNOLOGY & INFLAMMATION 2014-2022 ($ MILLION)
  • FIGURE 23. GLOBAL RAT MODEL MARKET BY OTHER DISEASES 2014-2022 ($ MILLION)
  • FIGURE 24. GLOBAL RAT MODEL MARKET BY FEED 2014-2022 ($ MILLION)
  • FIGURE 25. GLOBAL RAT MODEL MARKET BY BEDDING 2014-2022 ($ MILLION)
  • FIGURE 26. GLOBAL RAT MODEL MARKET BY CAGES 2014-2022 ($ MILLION)
  • FIGURE 27. GLOBAL RAT MODEL MARKET BY OTHER CARE PRODUCTS 2014-2022 ($ MILLION)
  • FIGURE 28. GLOBAL RAT MODEL MARKET BY CRYOPRESERVATION 2014-2022 ($ MILLION)
  • FIGURE 29. GLOBAL RAT MODEL MARKET BY BREEDING 2014-2022 ($ MILLION)
  • FIGURE 30. GLOBAL RAT MODEL MARKET BY GENETIC TESTING 2014-2022 ($ MILLION)
  • FIGURE 31. GLOBAL RAT MODEL MARKET BY OTHER SERVICES 2014-2022 ($ MILLION)
  • FIGURE 32. UNITED STATES (U.S.) RAT MODEL MARKET 2014-2022 ($ MILLION)
  • FIGURE 33. CANADA RAT MODEL MARKET 2014-2022 ($ MILLION)
  • FIGURE 34. UNITED KINGDOM (UK) RAT MODEL MARKET 2014-2022 ($ MILLION)
  • FIGURE 35. FRANCE RAT MODEL MARKET 2014-2022 ($ MILLION)
  • FIGURE 36. GERMANY RAT MODEL MARKET 2014-2022 ($ MILLION)
  • FIGURE 37. SPAIN RAT MODEL MARKET 2014-2022 ($ MILLION)
  • FIGURE 38. ITALY RAT MODEL MARKET 2014-2022 ($ MILLION)
  • FIGURE 39. ROE RAT MODEL MARKET 2014-2022 ($ MILLION)
  • FIGURE 40. INDIA RAT MODEL MARKET 2014-2022 ($ MILLION)
  • FIGURE 41. CHINA RAT MODEL MARKET 2014-2022 ($ MILLION)
  • FIGURE 42. JAPAN RAT MODEL MARKET 2014-2022 ($ MILLION)
  • FIGURE 43. SOUTH KOREA RAT MODEL MARKET 2014-2022 ($ MILLION)
  • FIGURE 44. AUSTRALIA RAT MODEL MARKET 2014-2022 ($ MILLION)
  • FIGURE 45. REST OF APAC RAT MODEL MARKET 2014-2022 ($ MILLION)
  • FIGURE 46. LATIN AMERICA RAT MODEL MARKET 2014-2022 ($ MILLION)
  • FIGURE 47. MENA RAT MODEL MARKET 2014-2022 ($ MILLION)
  • FIGURE 48. AFRICA RAT MODEL MARKET 2014-2022 ($ MILLION)
Back to Top